The aim of this study was to establish sensitive techniques for the detection of residual germ cell tumor cells in peripheral blood and progenitor cell harvests. For this purpose, we used immunocytochemical staining for cytokeratin filaments and reverse transcriptasepolymerase chain reaction (RT-PCR) for epidermal growth factor receptor (EGF-R) and germ cell alkaline phosphatase (GCAP). Germ cell tumor lines Tera-1 and Tera-2 were titrated into normal peripheral blood. 
cant portion of labelled cells within sites of relapse in patients with neuroblastoma, suggesting that reinfused tumor cells may, in fact, contribute to relapse. 4 In patients with follicular lymphoma, the reduction in contaminating tumor cells by purging autologous transplants to PCRnegativity, ie disappearance of a t(14;18) translocation-specific amplification product, has been shown to be associated with a better treatment outcome than in t(14;18) translocation amplification product-positive autografts. 5 These results emphasize the need for sensitive methods for tumor cell detection. Immunocytochemical staining and reverse transcriptase-polymerase chain reaction (RT-PCR) have been demonstrated to be sensitive and specific techniques for detecting micrometastases and residual disease. 6, 7 The former technique may allow exact cell determination as reported for tumors of epithelial origin, 7, 8 but is timeconsuming and may be less sensitive than RT-PCR. We used immunocytochemical staining to detect cytokeratin, since germ cell tumors have been described to express cytokeratin filaments. 9 For RT-PCR, EGF receptor mRNA was used as a target sequence, because it allows a sensitive detection of epithelial tumor cells in peripheral blood and progenitor cell harvests. 10 Furthermore, EGF receptor is expressed in most tissues with the exception of the hematopoietic system. 11 Finally, we investigated the feasibility of a novel target sequence, germ cell alkaline phosphatase (GCAP), for RT-PCR analysis.
Patients and methods

Patients
Patients with advanced testicular cancer (n = 7) and patients who relapsed after conventional treatment (n = 13) were enrolled for a high-dose chemotherapy regimen as described. 12 The first group included patients with unequivocal non-seminomatous germ cell tumors and either primary mediastinal germ cell tumor manifestations or those fulfilling the 'poor prognosis' criteria according to the recent International Germ Cell Cancer Collaborative Group (IGCCCG) classification. 13 The second group consisted of patients who relapsed after at least four cycles of a cisplatinum-based chemotherapy. All patients received a first cycle of chemotherapy consisting of either taxol (175 mg/m 2 day 1) and ifosfamide (5 g/m 2 day 1) or cis-platinum (20 mg/m 2 days 1-5), etoposide (100 mg/m 2 days 1-5) and ifosfamide (2.5 g/m 2 days 1-5). Thereafter, patients received 5 g G-CSF s.c. per kg of body weight daily, beginning from day 3 (TI) or day 7 (PEI). Peripheral blood progenitor cell aphereses were performed using an AS 104 (Fresenius AG, St Wendel, Germany) or a Cobe Spectra cell collector (Cobe Laboratories, Heimstetten, Germany). At time of apheresis, an aliquot of peripheral blood and of the apheresis product were processed for tumor cell detection. In one patient (patient No. 15), bone marrow was collected instead of peripheral blood progenitor cells. All patients enrolled in the study gave their written informed consent, and the study was approved by the local ethics committee.
Cell lines
Cell lines Tera-1 (germ cell tumor of seminomatous origin) and Tera-2 (germ cell tumor of non-seminomatous origin) were purchased from the American Type Culture Collection (Rockville, MD, USA). The cells were grown in McCoy's 5A medium containing 10% fetal calf serum and 1 mmol glutamine without addition of antibiotics. The other cell lines were grown in RPMI 1640 (Jurkat, Raji and U266) or Dulbecco's MEM (HepG2) containing 10% fetal calf serum. Fetal calf serum and media were purchased from Biochrom (Berlin, Germany).
RNA preparation
Peripheral blood mononuclear cells were separated on a Ficoll-Hypaque gradient (Pharmacia, Uppsala, Sweden), washed twice with PBS containing 1% FCS, counted and tested for viability by the use of trypan blue exclusion.
The cells were lysed in TRIzol reagent (GIBCO BRL, Grand Island, NY, USA) and sheared to homogeneity, following a one-step guanidinium isothiocyanate/phenol RNA preparation technique.
14 Chloroform was added, and the RNA contained in the aqueous upper phase was precipitated in isopropanol at −80°C, washed in 80% ethanol and resuspended in RNAse-free water.
The integrity of RNA was examined by RT-PCR analysis for ␤ 2 microglobulin mRNA. 15 
cDNA synthesis and PCR
Ten micrograms of RNA were incubated with 50 ng of a 15(dT) primer at 60°C for 10 min. After addition of deoxynucleotide mix (10 mm), DTT (10 mm) and first-strand reaction buffer, 100 U MMLV reverse transcriptase (GIBCO BRL) were added to a final volume of 50 l. The cDNA synthesis reaction was carried out at 37°C for 40 min. After heat inactivation at 95°C for 5 min and subsequent maintenance at 4°C, 5 l of each reaction product were subjected to PCR analysis.
The PCR reaction was carried out at 94°C (40 s), 60°C (for ␤ 2 microglobulin and EGF receptor primers) or 65°C (for germ cell alkaline phosphatase primers, 1 min) and 72°C (1 min) for 40 cycles, followed by a final 5 min at 72°C. All reagents employed for PCR analysis were purchased from InViTek (Berlin, Germany). Twenty microliters of the final PCR products were separated on a 1% agarose gel (Oncor Appligene, Heidelberg, Germany). For reamplification ('semi-nested' RT-PCR), 5 l of the PCR product were again subjected to 40 cycles of PCR using a nested sense primer. RNA preparation and PCR were carried out in separate locations to avoid any contamination. Oligonucleotides used in this study were chosen from published mRNA sequences. The sequences of the primers are listed in Table 1 .
Immunocytochemical staining
Ten micrograms of a murine F(ab) 2 fragment directed against cytokeratin (A45-B/B3, EpiMet Tumor Cell Detection Kit; Baxter Biotech, Unterschleißheim, Germany) were used for immunocytochemical staining. Cell suspensions were attached to slides by cytocentrifugation, air dried and stored at −20°C. The germ cell tumor cell line Tera-2 was used as a positive control for each immunostaining experiment. For anti-cytokeratin-F(ab) 2 staining, a standard protocol as outlined in the kit was followed. In brief, the slides were allowed to dry after thawing and permeabilized in methanol with 4% formaldehyde. The anti-cytokeratin F(ab) 2 fragment, being linked to alkaline phosphatase, allowed immediate staining with a chromogenic substrate.
Tumor cells were considered immunocytochemically positive when staining of more than 70% of cytoplasm was observed. Routinely, an overall number of 10 6 MNC, with 5 × 10 5 cells per slide, were analyzed and tumor cells quantified. The nucleotide sequences of the primers used for RT-PCR analyses are listed. The sequences of the amplification products correspond to the nucleotide positions in the original sequences derived from the European Molecular Biology Laboratory (EMBL) database as listed below each primer pair name.
Results
Expression of EGF receptor and germ cell alkaline phosphatase mRNA in tumor cell lines
RNA was isolated from different tumor cell lines and subjected to RT-PCR for EGF receptor and GCAP mRNA. Of the cell lines analyzed, bands for EGF receptor mRNA were detected for cell lines HepG2 (hepatocellular carcinoma), Tera-1 (germ cell tumor, seminomatous origin) and for Tera-2 (germ cell tumor, non-seminomatous origin). Primary amplification for GCAP mRNA yielded bands in samples derived from cell lines Tera-1 and Tera-2. RNA derived from HepG2 became positive after secondary amplification using 'semi-nested' primers. The other cell lines tested, Raji (Burkitt-like lymphoma), Jurkat (T cell acute leukemia) and U266 (multiple myeloma) remained negative for GCAP mRNA.
Immunocytochemical staining of HepG2, Tera-1 and Tera-2 cells showed positivity for cytokeratin filaments, whereas the other cell lines tested were negative. 6 mononuclear cells. Reamplification of the PCR product using semi-nested primers helped only to enhance the intensity of the bands detected after the first amplification. For Tera-2 dilutions, the maximum sensitivity achieved was one tumor cell in 10 4 PBMC. Reamplification did not result in a higher sensitivity but, again, rather in enhancement of the previously detected bands.
Detection of germ cell tumor cells by immunocytochemical staining and RT-PCR
The controls, peripheral blood mononuclear cells and peripheral blood progenitor cell harvests from healthy volunteers donors, were negative in all cases by immunocytochemical staining, and by RT-PCR for GCAP mRNA, even after secondary amplification (Figure 1 ).
Tumor cells in peripheral blood and progenitor cell harvests from patients with germ cell tumors
Samples from 20 patients were processed and analyzed by immunocytochemical staining for cytokeratin and RT-PCR 
The results of the analyses for contaminating tumor cells in peripheral blood ('periph. blood') and progenitor cell harvests ('harvest') by the use of immunocytochemical staining for cytokeratin and RT-PCR for germ cell alkaline phosphatase are presented. RT-PCR analysis revealed positivity for GCAP mRNA in seven patient samples. Bands were detected in the progenitor cell harvests of five patients (secondary amplification, ie semi-nested PCR), only in the peripheral blood of one other patient (Figure 2) , and in peripheral blood as well as progenitor cell harvest of a seventh patient. In this latter patient, the peripheral blood sample became positive only after secondary amplification, whereas the progenitor cell harvest was already positive after the primary amplification.
Discussion
The presence of residual tumor cells in peripheral blood and progenitor cell harvests has not yet been addressed in patients with germ cell tumors. In this study, we were able to detect such malignant cells by the use of immunocytochemical staining and RT-PCR.
The sensitivity of both techniques was evaluated using serial dilutions of germ cell tumor cells in normal mononuclear cells of peripheral blood. The results showed a high sensitivity of the immunocytochemical approach in both cell lines (1 tumor cell in 10 5 mononuclear cells). In our analyses, EGF receptor RT-PCR revealed a sensitivity of one tumor cell in 10 3 mononuclear cells for Tera-2 and only 1 tumor cell in 10 mononuclear cells in Tera-1. Since reamplification of the PCR product using nested primers led to false-positive reactions, the sensitivity of this assay could not be further enhanced. In contrast, the detection of tumor cells by amplification of germ cell alkaline phosphatase mRNA was highly sensitive and allowed the detection of one Tera-1 tumor cell in at least 10 6 mononuclear cells. For Tera-2, the sensitivity of RT-PCR appears to be slightly lower than that of immunocytochemical staining.
To date, RT-PCR represents the only technique that can unambiguously distinguish between germ cell alkaline phosphatase and placental alkaline phosphatase. The two Table 2 . The samples of peripheral blood are presented under the letter 'A', the samples drawn from progenitor cell harvests under the letter 'B'. As a negative control ('NC'), an additional RT-PCR reaction was performed without addition of RNA. isoenzymes have been demonstrated to differ only by 7 to 11 amino acid residues. 16 Unfortunately, there was no immunological reagent specific for germ cell alkaline phosphatase available. Therefore, we could neither investigate the correlation between germ cell alkaline phosphatase mRNA and protein expression, nor perform immunocytochemical staining for germ cell alkaline phosphatase for detection of germ cell tumor cells.
Consistent with previous reports, 17 all malignant cell lines of hematopoietic origin tested in our study were negative for EGF receptor mRNA. Both germ cell tumor cell lines used in our study, Tera-1 and -2, and HepG2, a hepatocellular carcinoma cell line, were found to be positive for EGF receptor mRNA.
Germ cell alkaline phosphatase has been described as a marker of carcinoma in situ of the testis, assigning a high sensitivity to this protein for the detection of tumor cells. 18 For this reason, we investigated the feasibility of germ cell alkaline phosphatase to serve as a marker for tumor cell detection. RT-PCR analysis showed significant expression of germ cell alkaline phosphatase mRNA in Tera-1 and -2 and weak expression in RNA derived from HepG2. Previous studies have demonstrated weak expression of germ cell alkaline phosphatase in testis, thymus, lung, cervix 19 and in several non-germ cell tumors as well. [20] [21] [22] Twenty samples of normal peripheral blood and five samples of progenitor cell harvests tested negative for GCAP mRNA (Figure 1 ). Since the samples of peripheral blood were collected by venepuncture, a contamination by epithelial or other non-hematopoietic cells has to be taken into account. However, immunocytochemical staining of all control samples for cytokeratin-positive cells showed no positivity. Additionally, in previous studies 40 samples of normal peripheral blood collected by venepuncture were negative for EGFR mRNA. Based on our results, mononuclear cells of the peripheral blood do not appear to express germ cell alkaline phosphatase. Thus, RT-PCR assays for GCAP mRNA appear to be a useful tool for the detection of germ cell tumor cells in peripheral blood.
The prospective analysis of samples drawn at day of apheresis revealed that circulating tumor cells can be detected in both the peripheral blood and progenitor cell harvests of patients with advanced germ cell tumors. Immunocytochemical staining demonstrated tumor cell contamination in three out of 20 patients, two of whom had tumor cells in peripheral blood and progenitor cell harvests, and one of whom had tumor cells in the progenitor cell harvesting product only. Based on an estimated detection efficiency of 20% as derived from the dilution experiments, an overall tumor cell contamination of 1 in 10 5 mononuclear cells can be assumed. This amount of contaminating cells is similar to that of tumor cells in peripheral blood and progenitor cell harvests of breast cancer patients. 7 GCAP RT-PCR was positive in seven of 20 patients. In one patient, tumor cell contamination was revealed by immunocytochemical staining but not by RT-PCR. An explanation for this finding might be a lower expression of germ cell alkaline phosphatase in the tumor cells detected, which, in this patient, would result in a reduced sensitivity of the RT-PCR assay. This assumption is further substantiated by the comparative analysis of the serial dilutions, in which the sensitivity of the immunocytochemical approach was inferior to RT-PCR in Tera-1, but superior in Tera-2 dilutions. Our observation is in accordance with the data reported by Schär et al 23 who showed that the differential expression of alkaline phosphatase isoenzymes in germ cell tumors depends on the respective degree of tumor differentiation. However, this finding does not appear to limit the feasibility of the assay for sensitive detection of germ cell tumor cells in peripheral blood.
The number of clinical samples analyzed in our study does not allow us to draw conclusions regarding a possible correlation between the presence of circulating tumor cells and other prognostic factors. Further studies are needed to evaluate more precisely the extent of tumor cell contamination in peripheral blood and progenitor cell harvests of patients with germ cell tumor, and to elucidate the impact of these findings on the patients' outcome and survival.
